Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	238	150	127	206	148	173.42
Short-Term Investments	593	828	632	803	351	555.23
Cash & Short-Term Investments	831	978	759	1,009	499	728.65
Cash Growth	-23.69%	28.85%	-24.78%	102.20%	-31.52%	287.02%
Accounts Receivable	11	20	38	39	745	1.05
Other Receivables	3	5	4	4	2	0.65
Receivables	14	25	42	43	747	1.7
Prepaid Expenses	12	13	30	15	16	5.47
Total Current Assets	857	1,016	831	1,067	1,262	735.82
Property, Plant & Equipment	42	112	143	135	137	23.59
Long-Term Investments	10	14	107	129	182	6.44
Other Long-Term Assets	65	8	14	14	11	6.45
Total Assets	974	1,150	1,095	1,345	1,592	772.29
Accounts Payable	42	18	17	20	10	15.68
Accrued Expenses	112	96	62	70	47	27.85
Current Portion of Leases	13	12	11	3	-	-
Current Income Taxes Payable	-	1	-	-	2	-
Current Unearned Revenue	52	85	91	97	102	74.57
Other Current Liabilities	16	14	3	3	5	3.57
Total Current Liabilities	235	226	184	193	166	121.67
Long-Term Debt	119	48	-	-	-	-
Long-Term Leases	-	99	110	117	117	15.24
Long-Term Unearned Revenue	53	234	307	355	462	132.53
Other Long-Term Liabilities	131	58	32	23	5	0.54
Total Liabilities	538	665	633	688	750	269.99
Common Stock	1,815	1,617	1,311	1,206	1,118	0.01
Additional Paid-In Capital	-	-	-	-	-	830.44
Retained Earnings	-1,379	-1,132	-849	-542	-275	-328.18
Comprehensive Income & Other	-	-	-	-7	-1	0.04
Total Common Equity	436	485	462	657	842	502.3
Shareholders' Equity	436	485	462	657	842	502.3
Total Liabilities & Equity	974	1,150	1,095	1,345	1,592	772.29
Total Debt	132	159	121	120	117	15.24
Net Cash (Debt)	709	833	745	1,018	564	713.4
Net Cash Growth	-29.94%	11.81%	-26.82%	80.50%	-20.94%	278.93%
Net Cash Per Share	7.04	9.25	10.07	14.14	7.62	13.02
Filing Date Shares Outstanding	107.97	105.84	90.86	73.01	71.06	70.88
Total Common Shares Outstanding	107.1	92.2	75.5	72.9	70.78	65.11
Working Capital	622	790	647	874	1,096	614.15
Book Value Per Share	4.07	5.26	6.12	9.01	11.90	7.71
Tangible Book Value	436	485	462	657	842	502.3
Tangible Book Value Per Share	4.07	5.26	6.12	9.01	11.90	7.71
Machinery	-	31	27	20	16	11.42
Construction In Progress	-	1	1	4	2	2.34
Leasehold Improvements	-	56	54	34	32	11.11

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q